BRCA Challenge: BRCA Exchange as a global resource for variants in BRCA1 and BRCA2
Open Access
- 26 December 2018
- journal article
- research article
- Published by Public Library of Science (PLoS) in PLOS Genetics
- Vol. 14 (12) , e1007752
Abstract
The BRCA Challenge is a long-term data-sharing project initiated within the Global Alliance for Genomics and Health (GA4GH) to aggregate BRCA1 and BRCA2 data to support highly collaborative research activities. Its goal is to generate an informed and current understanding of the impact of genetic variation on cancer risk across the iconic cancer predisposition genes, BRCA1 and BRCA2. Initially, reported variants in BRCA1 and BRCA2 available from public databases were integrated into a single, newly created site, www.brcaexchange.org. The purpose of the BRCA Exchange is to provide the community with a reliable and easily accessible record of variants interpreted for a high-penetrance phenotype. More than 20,000 variants have been aggregated, three times the number found in the next-largest public database at the project’s outset, of which approximately 7,250 have expert classifications. The data set is based on shared information from existing clinical databases—Breast Cancer Information Core (BIC), ClinVar, and the Leiden Open Variation Database (LOVD)—as well as population databases, all linked to a single point of access. The BRCA Challenge has brought together the existing international Evidence-based Network for the Interpretation of Germline Mutant Alleles (ENIGMA) consortium expert panel, along with expert clinicians, diagnosticians, researchers, and database providers, all with a common goal of advancing our understanding of BRCA1 and BRCA2 variation. Ongoing work includes direct contact with national centers with access to BRCA1 and BRCA2 diagnostic data to encourage data sharing, development of methods suitable for extraction of genetic variation at the level of individual laboratory reports, and engagement with participant communities to enable a more comprehensive understanding of the clinical significance of genetic variation in BRCA1 and BRCA2. The goal of this study and paper has been to develop an international resource to generate an informed and current understanding of the impact of genetic variation on cancer risk across the cancer predisposition genes, BRCA1 and BRCA2. Reported variants in BRCA1 and BRCA2 available from public databases were integrated into a single, newly created site, www.brcaexchange.org, to provide a reliable and easily accessible record of variants interpreted for a high-penetrance phenotype.Keywords
Funding Information
- Intramural Research Program
- Beau Biden Moonshot Act
- NHMRC Senior Research Fellowship (1061779)
- Can-SHARE (141210)
- National Cancer Institute’s ITCR program (5U24CA180951-05)
- National Cancer Institute’s ITCR program (5U24CA210974-02)
- National Human Genome Research Institute (R01 HG 008918)
- National Human Genome Research Institute (U54HG007990)
- ETH Zurich (core) funding
- Educational Grant from Astra Zeneca
- ClinGen grant (U41HG006834)
- Breast Cancer Research Foundation and MSKCC Cancer Center (P30 CA008748)
- National Cancer Institute (U24CA210999)
- Basser Center for BRCA
- N/A (1U41HG009649)
- Canadian Institutes of Health Research (FDN-148390)
This publication has 44 references indexed in Scilit:
- Evolution and Functional Impact of Rare Coding Variation from Deep Sequencing of Human ExomesScience, 2012
- The 1000 Genomes Project: data management and community accessNature Methods, 2012
- Classification of missense substitutions in the BRCA genes: A database dedicated to Ex-UVsHuman Mutation, 2011
- ENIGMA-Evidence-based network for the interpretation of germline mutant alleles: An international initiative to evaluate risk and clinical significance associated with sequence variation in BRCA1 and BRCA2 genesHuman Mutation, 2011
- A review of a multifactorial probability-based model for classification of BRCA1 and BRCA2 variants of uncertain significance (VUS)Human Mutation, 2011
- Sequence variant classification and reporting: recommendations for improving the interpretation of cancer susceptibility genetic test resultsHuman Mutation, 2008
- A Systematic Genetic Assessment of 1,433 Sequence Variants of Unknown Clinical Significance in the BRCA1 and BRCA2 Breast Cancer–Predisposition GenesThe American Journal of Human Genetics, 2007
- An international initiative to identify genetic modifiers of cancer risk in BRCA1 and BRCA2 mutation carriers: the Consortium of Investigators of Modifiers of BRCA1 and BRCA2 (CIMBA)Breast Cancer Research, 2007
- Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 StudiesThe American Journal of Human Genetics, 2003
- Identification of the breast cancer susceptibility gene BRCA2Nature, 1995